These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31981687)

  • 21. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats.
    Santhosh S; Sini TK; Anandan R; Mathew PT
    Eur J Pharmacol; 2007 Oct; 572(1):69-73. PubMed ID: 17612523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
    Kozma D; Mihalik P; Schaff Z; Lapis K
    Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by
    Ruan LY; Fan JT; Hong W; Zhao H; Li MH; Jiang L; Fu YH; Xing YX; Chen C; Wang JS
    Toxicol Lett; 2018 Oct; 295():256-269. PubMed ID: 29936297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
    Labana S; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2002 Oct; 20(4):301-4. PubMed ID: 12385689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ameliorative Effects of Kolaviron, a Biflavonoid Fraction from Garcinia Kola Seed, on Hepato-renal Toxicity of Anti-tuberculosis Drugs in Wistar Rats.
    Adaramoye OA; Kehinde AO; Adefisan A; Adeyemi O; Oyinlola I; Akanni OO
    Tokai J Exp Clin Med; 2016 Mar; 41(1):14-21. PubMed ID: 27050890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoprotective effect of tocopherol against isoniazid and rifampicin induced hepatotoxicity in albino rabbits.
    Tayal V; Kalra BS; Agarwal S; Khurana N; Gupta U
    Indian J Exp Biol; 2007 Dec; 45(12):1031-6. PubMed ID: 18254208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance.
    Du Preez I; Loots DT
    Drug Metab Rev; 2018 Nov; 50(4):466-481. PubMed ID: 30558443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
    Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
    Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
    Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
    Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.
    Villegas L; Otero L; Sterling TR; Huaman MA; Van der Stuyft P; Gotuzzo E; Seas C
    PLoS One; 2016; 11(4):e0152933. PubMed ID: 27045684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and operational value of the extensively drug-resistant tuberculosis definition.
    Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC;
    Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
    García-Rodríguez JF; Valcarce-Pardeiro N; Álvarez-Díaz H; Mariño-Callejo A
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2121-2126. PubMed ID: 31377953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity.
    Tasduq SA; Kaisar P; Gupta DK; Kapahi BK; Maheshwari HS; Jyotsna S; Johri RK
    Phytother Res; 2005 Mar; 19(3):193-7. PubMed ID: 15934014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of methanolic extract of Annona squamosa Linn in isoniazid-rifampicin induced hepatotoxicity in rats.
    Thattakudian Sheik Uduman MS; Sundarapandian R; Muthumanikkam A; Kalimuthu G; Parameswari S A; Vasanthi Srinivas TR; Karunakaran G
    Pak J Pharm Sci; 2011 Apr; 24(2):129-34. PubMed ID: 21454160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
    Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
    Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.